With a blood test, doctors might someday detect cancer in the earliest stages. That's the dream of a handful of start-ups in the so-called "liquid biopsy" space. The companies are sequencing DNA from circulating cancer cells in the blood and are raising massive amounts of cash to bring this technology from the lab to medical clinics in the next decade....